Core Viewpoint - The collaboration between Yimai Sunshine and its partners aims to leverage a regulatory framework for data processing and compliance to create a high-quality medical imaging database, facilitating innovative applications in the field of medical imaging data [1][2] Group 1: Collaboration Details - Yimai Sunshine's subsidiary, Beijing Yimai, signed a data co-construction cooperation agreement with Beijing Data Pilot Zone Service Co., Ltd. and Beijing International Computing Power Service Co., Ltd. [1] - The partnership focuses on utilizing medical imaging data resources provided by Yimai Sunshine, with responsibilities divided among the three parties for data processing, compliance verification, and computational support [1] Group 2: Commercialization and Impact - By the end of October 2025, the collaborative medical imaging database successfully achieved its first commercial transformation, offering a large model training service with fees reaching tens of millions of RMB [1] - This achievement signifies a substantial breakthrough for the company in the marketization and value realization of medical imaging data elements [1] - The board believes this collaboration aligns with national policies on the marketization of data elements and is expected to positively impact the company's business development [2]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不就因本公告全部或任何部分內容所產生或因依 賴該等內容而引致的任何損失承擔任何責任。 Jiangxi Rimag Group Co., Ltd. 江西一脈陽光集團股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：2522） 自願公告 醫學影像數據共建合作項目 本公告由江西一脈陽光集團股份有限公司（「本公司」，連同其附屬公司統稱為「本 集團」）董事（「董事」）會（「董事會」）自願作出。 董事會欣然宣佈，於2025年10月，本集團之附屬公司北京一脈陽光醫學信息技術 有限公司（「北京一脈」）與北京數據先行區服務有限公司（「北京先行區」）及北京 國際算力服務有限公司（「北京算力」）共同簽署《數據共建合作協議》。北京先行區 為經北京市經濟和信息化局授權開展北京人工智能數據沙盒（「數據沙盒」）試點工 作的運營主體，負責提供數據處理、合規評審及模型訓練支持；北京算力則提供 可信存儲與算力資源等技術基礎設施。 江西一脈陽光集團股份有限公司 本次合作旨在依托數據沙盒的合規監管框架，基於 ...

Core Viewpoint - The company has entered into an investment agreement to acquire additional equity in Yinghe Medical Technology, recognizing the rapid growth potential in the medical imaging AI sector and the increasing demand for precise and efficient imaging diagnostics [1][2][3] Group 1: Investment Details - The company will invest nearly 100 million RMB to subscribe to the new registered capital of Yinghe Medical Technology, which will increase its total equity stake in the company [1] - This investment is part of the company's strategy to enhance its presence in the medical imaging AI sector, aligning with its long-term development plans [2] Group 2: Strategic Importance - The investment is expected to activate a "twin incubation" development mechanism, leveraging the company's quality data resources and Yinghe's AI technology to create a mutually beneficial growth environment [2] - By enhancing its industrial chain layout through this investment, the company aims to transition towards a data-driven service model, improving its core competitive strength in the industry [2] Group 3: Market Positioning - The investment will significantly improve the diagnostic accuracy and efficiency of the company's imaging centers and partner medical institutions, better meeting clinical needs [2] - This strategic move is anticipated to strengthen the company's position in the rapidly growing imaging AI field, allowing it to seize industry development opportunities and achieve sustained business growth [3]

Core Viewpoint - The company has signed a capital increase agreement with Shanghai Yinghe Medical Technology Co., Ltd., investing nearly 100 million RMB to enhance its stake, reflecting a strategic move to strengthen its position in the rapidly growing medical imaging AI sector [1][2]. Group 1: Investment and Strategic Importance - The investment is part of the company's strategy to implement a three-in-one model of medical imaging AI, which includes medical imaging data, AI foundational models, and imaging center scenarios [2]. - This capital connection is expected to activate a "twin incubation" development mechanism, leveraging the company's accumulated quality data resources and Yinghe Medical's AI technology to create a mutually beneficial development cycle [2][3]. Group 2: Market Position and Competitive Advantage - The investment will enhance the company's industrial chain layout, improve service quality, and strengthen its competitive position in the fast-growing imaging AI field [2][3]. - By utilizing Yinghe Medical's technological advantages, the company aims to transition towards a data-driven service model, thereby increasing its core competitiveness in the industry [2]. - The anticipated outcome of this investment is to solidify the company's leadership position in China's medical imaging AI sector through the construction of a comprehensive "data + algorithm + scenario" closed-loop system [3].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不就因本公告全部或任何部分內容所產生或因依 賴該等內容而引致的任何損失承擔任何責任。 Jiangxi Rimag Group Co., Ltd. 江西一脈陽光集團股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：2522） 自願公告 增資於一家醫學影像人工智能公司 本公告由江西一脈陽光集團股份有限公司（「本公司」或「一脈陽光」），連同其附屬 公司統稱（「本集團」）董事（「董事」）會（「董事會」）自願作出。 董事會欣然宣佈，於2025年10月29日（「簽署日」），本公司與上海影禾醫脈智能科 技有限公司（「影禾醫脈」）及其相關各方訂立《增資認購協議》（「協議」）。據此， 本公司以總代價近億元人民幣認購影禾醫脈的新增註冊資本。本次交易完成後， 本公司於影禾醫脈的持股總權益將進一步提升。 董事會認為，醫學影像人工智能作為醫療科技領域未來的核心發展方向，正迎來 市場需求快速釋放的黃金階段。隨著醫療數字化轉型加速，臨床對精準化、高效 化影像診斷的需求日益迫切，這一領域的市場空間將 ...

Core Viewpoint - The 2025 Pujiang Innovation Forum, themed "Shared Innovation to Shape the Future: Building an Open and Cooperative Global Technology Community," opened in Shanghai, highlighting international collaboration in technology and innovation [1] Group 1: Forum Overview - The forum is co-hosted by the Ministry of Science and Technology of the People's Republic of China and the Shanghai Municipal Government, with Belarus as the guest country and Liaoning Province as the guest province [1] - This year's forum has the largest scale and number of participants in its history, with over 550 guests from more than 300 institutions across 45 countries and regions [1] Group 2: Key Activities and Initiatives - The forum features over 30 specialized forums and closed-door meetings focusing on cutting-edge fields such as AI for Science, quantum intelligence, and controllable nuclear fusion, with participation from top global scientific award winners [2] - The InnoMatch technology transfer conference will globally release 10,000 technology demands, with over 20 billion yuan in corporate investment, and showcase 2,000 talent demand positions along with over 80 first-time products and experience scenarios [2] - The WeStart entrepreneurship investment conference will stimulate innovation and entrepreneurship through diverse formats, with 1,487 teams registered, including 71 international projects, and 100 quality projects selected for roadshows [2] Group 3: Forum's Mission and History - Since its inception in 2008, the Pujiang Innovation Forum has been held 18 times, aiming to inspire innovative thinking, disseminate innovative concepts, and motivate innovative spirit [3] - The forum serves as an important platform for international scientific cooperation, national technological innovation practices, and a gathering space for global scientists and entrepreneurs [3]